封面
市场调查报告书
商品编码
1663023

虚拟临床试验市场规模、份额、成长分析,按研究设计、类型、阶段、适应症、产业垂直和地区划分 - 产业预测,2025 年至 2032 年

Virtual Clinical Trials Market Size, Share, and Growth Analysis, By Study Design (Interventional, Observational), By Type (Fully virtual trials, Hybrid virtual trials), By Phases, By Indication, By Industry, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2023 年全球虚拟临床试验 (VCT) 市场规模价值为 93 亿美元,预计将从 2024 年的 99 亿美元成长到 2032 年的 162.5 亿美元,预测期内(2025-2032 年)的复合年增长率为 6.4%。

全球医疗保健市场正在经历显着增长,这主要归因于医疗保健基础设施数位化的加速。虚拟临床试验在皮肤病学测试中的应用越来越广泛,进一步推动了这一成长。这些测试旨在帮助评估不需要复杂测试的皮肤状况。 COVID-19 疫情推动了对安全虚拟检查解决方案的需求并促进了有效的资料收集。此外,虚拟病人互动平台和穿戴式装置等技术进步正在透过远端医疗增强医病联繫。然而,由于缺乏标准化的指导方针以及需要有效管理大量信息,市场扩张可能会面临挑战。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 次要和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024 年)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析

虚拟临床试验市场规模:研究设计

  • 市场概况
  • 介入
  • 观察
  • 扩大访问范围

虚拟临床试验市场规模(按类型)

  • 市场概况
  • 完全虚拟试用
  • 混合虚拟审判

虚拟临床试验市场按阶段分類的规模

  • 市场概况
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

虚拟临床试验市场规模(依适应症划分)

  • 市场概况
  • 中枢神经系统
  • 自体免疫/炎症
  • 心血管疾病
  • 代谢和内分泌学
  • 感染疾病
  • 肿瘤学
  • 泌尿生殖系统
  • 眼科
  • 其他适应症

虚拟临床试验市场规模(按行业)

  • 市场概况
  • 製药和生物技术公司
  • 合约研究组织(CRO)
  • 医疗设备公司
  • 其他行业

虚拟临床试验市场规模

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲国家
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前 5 家公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采用的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024 年)
  • 主要企业简介
    • 公司详细信息
    • 产品系列分析
    • 公司分部份额分析
    • 收益与前一年同期比较对比(2022-2024 年)

主要企业简介

  • IQVIA(USA)
  • ICON plc(Ireland)
  • Parexel International(USA)
  • Charles River Laboratories(USA)
  • Medidata Solutions(USA)
  • Oracle Health(USA)
  • PRA Health Sciences(USA)
  • Pharmaleads(USA)
  • Medpace(USA)
  • Certara(USA)
  • Syntract(USA)
  • Velocity Clinical Research(USA)
  • INC Research(USA)

结论和建议

简介目录
Product Code: SQMIG35D2037

Global Virtual Clinical Trials Market size was valued at USD 9.3 billion in 2023 and is poised to grow from USD 9.9 billion in 2024 to USD 16.25 billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).

The global healthcare market is witnessing significant growth, primarily due to the accelerated digitization of healthcare infrastructure. The rising adoption of virtual clinical trials (VCT) for dermatological testing is further propelling this growth, as these trials facilitate the evaluation of skin conditions that do not involve intricate examinations. The COVID-19 pandemic has intensified the demand for safe virtual testing solutions, fostering effective data collection. Additionally, technological advancements, including the advent of virtual patient interaction platforms and wearable devices, are enhancing patient-clinician connectivity through telemedicine. However, market expansion may face challenges due to a lack of standardized guidelines and the necessity to manage the overwhelming influx of information effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Virtual Clinical Trials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Virtual Clinical Trials Market Segments Analysis

Global Virtual Clinical Trials Market is segmented by Study Design, Type, Phases, Indication, Industry and region. Based on Study Design, the market is segmented into Interventional, Observational and Expanded access. Based on Type, the market is segmented into Fully virtual trials and Hybrid virtual trials. Based on Phases, the market is segmented into Phase I, Phase II, Phase III and Phase IV. Based on Indication, the market is segmented into CNS, Autoimmune/inflammation, Cardiovascular disease, Metabolic/endocrinology, Infectious disease, Oncology, Genitourinary, Ophthalmology and Other indications. Based on Industry, the market is segmented into Pharmaceutical and biotechnology companies, Contract research organizations (CROs), Medical devices companies and Other industries. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Virtual Clinical Trials Market

One of the key drivers fueling the expansion of the Global Virtual Clinical Trials market is the advancement in real-time reporting and data collection. This innovative approach enables researchers to gather and analyze data instantaneously, enhancing the efficiency and accuracy of clinical trials. The ability to monitor participant responses and treatment effects in real time allows for more informed decision-making and timely adjustments to trial protocols. As a result, this capability not only accelerates the drug development process but also improves participant engagement and adherence. Consequently, the demand for virtual clinical trials is on the rise, transforming the landscape of clinical research.

Restraints in the Global Virtual Clinical Trials Market

One significant challenge facing the Global Virtual Clinical Trials market is the apprehension regarding data accuracy and security. As virtual trials heavily rely on the collection and management of sensitive patient information, concerns about the potential for data breaches and inaccuracies can hinder stakeholder confidence. The reliance on digital platforms increases the risk of unauthorized access to confidential data, leading to possible violations of privacy and regulatory standards. Consequently, these concerns may dissuade participation from patients and researchers alike, ultimately impacting the overall effectiveness and trustworthiness of virtual clinical trials in the healthcare landscape.

Market Trends of the Global Virtual Clinical Trials Market

The Global Virtual Clinical Trials market is poised for significant growth, driven by the increasing adoption of connected devices and innovative digital tools such as eCOA, ePRO, and eConsent. This shift towards a remote, participant-centric model is evidenced by the widespread acceptance of the bring-your-own-device strategy among Contract Research Organizations (CROs) and sponsors, enhancing data collection and analysis. Additionally, advancements in artificial intelligence are revolutionizing trial processes, expediting target validation and patient recruitment. The emergence of synthetic clinical trial methodologies further exemplifies the evolving landscape, positioning virtual trials as a viable and efficient alternative to traditional methods.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Virtual Clinical Trials Market Size by Study Design & CAGR (2025-2032)

  • Market Overview
  • Interventional
  • Observational
  • Expanded access

Global Virtual Clinical Trials Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Fully virtual trials
  • Hybrid virtual trials

Global Virtual Clinical Trials Market Size by Phases & CAGR (2025-2032)

  • Market Overview
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Global Virtual Clinical Trials Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • CNS
  • Autoimmune/inflammation
  • Cardiovascular disease
  • Metabolic/endocrinology
  • Infectious disease
  • Oncology
  • Genitourinary
  • Ophthalmology
  • Other indications

Global Virtual Clinical Trials Market Size by Industry & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical and biotechnology companies
  • Contract research organizations (CROs)
  • Medical devices companies
  • Other industries

Global Virtual Clinical Trials Market Size & CAGR (2025-2032)

  • North America (Study Design, Type, Phases, Indication, Industry)
    • US
    • Canada
  • Europe (Study Design, Type, Phases, Indication, Industry)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Study Design, Type, Phases, Indication, Industry)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Study Design, Type, Phases, Indication, Industry)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Study Design, Type, Phases, Indication, Industry)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • IQVIA (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICON plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Parexel International (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medidata Solutions (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oracle Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PRA Health Sciences (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pharmaleads (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medpace (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Certara (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Syntract (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Velocity Clinical Research (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • INC Research (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations